Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Hospital quality indicators: a systematic review.

Breyer JZ, Giacomazzi J, Kuhmmer R, Lima KM, Hammes LS, Ribeiro RA, Kops NL, Falavigna M, Wendland EM.

Int J Health Care Qual Assur. 2019 Mar 11;32(2):474-487. doi: 10.1108/IJHCQA-04-2018-0091.

PMID:
31017060
2.

p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.

Macedo GS, Vieira IA, Vianna FSL, Alemar B, Giacomazzi J, Brandalize APC, Caleffi M, Volc SM, de Campos Reis Galvão H, Palmero EI, Achatz MI, Ashton-Prolla P.

Fam Cancer. 2018 Apr;17(2):269-274. doi: 10.1007/s10689-017-0028-4.

PMID:
28756477
3.

Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.

Villacis RAR, Basso TR, Canto LM, Pinheiro M, Santiago KM, Giacomazzi J, de Paula CAA, Carraro DM, Ashton-Prolla P, Achatz MI, Rogatto SR.

J Mol Med (Berl). 2017 May;95(5):523-533. doi: 10.1007/s00109-017-1507-7. Epub 2017 Jan 16.

PMID:
28093616
4.

Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H in TP53.

Fitarelli-Kiehl M, Macedo GS, Schlatter RP, Koehler-Santos P, Matte Uda S, Ashton-Prolla P, Giacomazzi J.

Genet Mol Biol. 2016 Jun 3;39(2):203-9. doi: 10.1590/1678-4685-GMB-2014-0351.

5.

Retinoblastoma in a pediatric oncology reference center in Southern Brazil.

Selistre SGA, Maestri MK, Santos-Silva P, Schüler-Faccini L, Guimarães LSP, Giacomazzi J, Evangelista Júnior MC, Ashton-Prolla P.

BMC Pediatr. 2016 Apr 3;16:48. doi: 10.1186/s12887-016-0579-9.

6.

Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.

Macedo GS, Araujo Vieira I, Brandalize AP, Giacomazzi J, Inez Palmero E, Volc S, Rodrigues Paixão-Côrtes V, Caleffi M, Silva Alves M, Achatz MI, Hainaut P, Ashton-Prolla P.

Cancer Genet. 2016 Mar;209(3):97-106. doi: 10.1016/j.cancergen.2015.12.012. Epub 2016 Jan 7.

PMID:
26823150
7.

The burden of serious human fungal infections in Brazil.

Giacomazzi J, Baethgen L, Carneiro LC, Millington MA, Denning DW, Colombo AL, Pasqualotto AC; Association With The LIFE Program.

Mycoses. 2016 Mar;59(3):145-50. doi: 10.1111/myc.12427. Epub 2015 Dec 22.

PMID:
26691607
8.

Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p.

Paskulin DD, Giacomazzi J, Achatz MI, Costa S, Reis RM, Hainaut P, dos Santos SE, Ashton-Prolla P.

PLoS One. 2015 Nov 30;10(11):e0143262. doi: 10.1371/journal.pone.0143262. eCollection 2015.

9.

Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.

Giacomazzi CR, Giacomazzi J, Netto CB, Santos-Silva P, Selistre SG, Maia AL, Oliveira VZ, Camey SA, Goldim JR, Ashton-Prolla P.

Rev Assoc Med Bras (1992). 2015 May-Jun;61(3):282-9. doi: 10.1590/1806-9282.61.03.282. Review.

10.

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers.

Fitarelli-Kiehl M, Giacomazzi J, Santos-Silva P, Graudenz MS, Palmero EI, Michelli RA, Achatz MI, de Toledo Osório CA, de Faria Ferraz VE, Picanço CG, Ashton-Prolla P.

Fam Cancer. 2015 Jun;14(2):333-6. doi: 10.1007/s10689-015-9779-y.

PMID:
25564201
11.

Apolipoprotein E genetic polymorphism, serum lipoprotein levels and breast cancer risk: A case-control study.

Cibeira GH, Giacomazzi J, Aguiar E, Schneider S, Ettrich B, DE Souza CI, Camey S, Caleffi M, Weber B, Ashton-Prolla P, Moriguchi EH.

Mol Clin Oncol. 2014 Nov;2(6):1009-1015. Epub 2014 Aug 1.

12.

The Brazilian founder mutation TP53 p.R337H is uncommon in Portuguese women diagnosed with breast cancer.

Giacomazzi J, Correia RL, Palmero EI, Gaspar JF, Almeida M, Portela C, Camey SA, Monteiro A, Pinheiro M, Peixoto A, Teixeira MR, Reis RM, Ashton-Prolla P.

Breast J. 2014 Sep-Oct;20(5):534-6. doi: 10.1111/tbj.12308. Epub 2014 Jul 23.

PMID:
25052705
13.

Effects of lifestyle modification after breast cancer treatment: a systematic review protocol.

Falavigna M, Lima KM, Giacomazzi J, Paskulin Dd, Hammes LS, Ribeiro RA, Rosa DD.

Syst Rev. 2014 Jul 5;3:72. doi: 10.1186/2046-4053-3-72.

14.

Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.

Giacomazzi J, Graudenz MS, Osorio CA, Koehler-Santos P, Palmero EI, Zagonel-Oliveira M, Michelli RA, Scapulatempo Neto C, Fernandes GC, Achatz MI, Martel-Planche G, Soares FA, Caleffi M, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.

PLoS One. 2014 Jun 17;9(6):e99893. doi: 10.1371/journal.pone.0099893. eCollection 2014.

15.

PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines.

Izetti P, Hautefeuille A, Abujamra AL, de Farias CB, Giacomazzi J, Alemar B, Lenz G, Roesler R, Schwartsmann G, Osvaldt AB, Hainaut P, Ashton-Prolla P.

Invest New Drugs. 2014 Oct;32(5):783-94. doi: 10.1007/s10637-014-0090-9. Epub 2014 May 20.

PMID:
24838627
16.

Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.

Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.

Cancer. 2013 Dec 15;119(24):4341-9. doi: 10.1002/cncr.28346. Epub 2013 Oct 7.

17.

A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

Giacomazzi J, Koehler-Santos P, Palmero EI, Graudenz MS, Rivero LF, Lima E, Pütten AC, Hainaut P, Camey SA, Michelli RD, Neto CS, Fitarelli-Kiehl M, Geyer G, Meurer L, Geiger A, Azevedo MB, da Silva VD, Ashton-Prolla P.

Virchows Arch. 2013 Jul;463(1):17-22. doi: 10.1007/s00428-013-1439-8. Epub 2013 Jun 21.

PMID:
23794094
18.

TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.

Giacomazzi J, Selistre S, Duarte J, Ribeiro JP, Vieira PJ, de Souza Macedo G, Rossi C, Czepielewski M, Netto CB, Hainaut P, Ashton-Prolla P.

BMC Cancer. 2013 Apr 9;13:187. doi: 10.1186/1471-2407-13-187.

19.

Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening.

Isoppo de Souza C, Rosa DD, Ettrich B, Cibeira GH, Giacomazzi J, Tusset P, Ashton-Prolla P, Medeiros LR, Caleffi M, Neto EC, Moriguchi EH, Graudenz MS.

Nutr Metab (Lond). 2012 Oct 31;9(1):97. doi: 10.1186/1743-7075-9-97.

20.

Increased oxidative damage in carriers of the germline TP53 p.R337H mutation.

Macedo GS, Lisbôa da Motta L, Giacomazzi J, Netto CB, Manfredini V, Vanzin CS, Vargas CR, Hainaut P, Klamt F, Ashton-Prolla P.

PLoS One. 2012;7(10):e47010. doi: 10.1371/journal.pone.0047010. Epub 2012 Oct 9.

21.

GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening.

de Aguiar ES, Giacomazzi J, Schmidt AV, Bock H, Saraiva-Pereira ML, Schuler-Faccini L, Duarte Filho D, dos Santos PA, Giugliani R, Caleffi M, Camey SA, Ashton-Prolla P.

Rev Bras Epidemiol. 2012 Jun;15(2):246-55.

22.

Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women.

Giacomazzi J, Aguiar E, Palmero EI, Schmidt AV, Skonieski G, Filho DD, Bock H, Saraiva-Pereira ML, Ewald IP, Schuler-Faccini L, Camey SA, Caleffi M, Giugliani R, Ashton-Prolla P.

Braz J Med Biol Res. 2012 Oct;45(10):891-7. Epub 2012 May 17.

23.

Prevalence of the STK15 F31I polymorphism and its relationship with mammographic density.

Giacomazzi J, Aguiar E, Palmero EI, Schmidt AV, Skonieski G, Duarte Filho D, Bock H, Saraiva-Pereira ML, Schuler-Faccini L, Camey SA, Caleffi M, Giugliani R, Ashton-Prolla P.

Braz J Med Biol Res. 2011 Apr;44(4):291-6. Epub 2011 Mar 11.

24.

Adherence to a breast cancer screening program and its predictors in underserved women in southern Brazil.

Caleffi M, Ribeiro RA, Bedin AJ Jr, Viegas-Butzke JM, Baldisserotto FD, Skonieski GP, Giacomazzi J, Camey SA, Ashton-Prolla P.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2673-9. doi: 10.1158/1055-9965.EPI-10-0338. Epub 2010 Aug 17.

25.

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Ashton-Prolla P, Giacomazzi J, Schmidt AV, Roth FL, Palmero EI, Kalakun L, Aguiar ES, Moreira SM, Batassini E, Belo-Reyes V, Schuler-Faccini L, Giugliani R, Caleffi M, Camey SA.

BMC Cancer. 2009 Aug 14;9:283. doi: 10.1186/1471-2407-9-283.

26.

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.

Palmero EI, Caleffi M, Schüler-Faccini L, Roth FL, Kalakun L, Netto CB, Skonieski G, Giacomazzi J, Weber B, Giugliani R, Camey SA, Ashton-Prolla P.

Genet Mol Biol. 2009 Jul;32(3):447-55. doi: 10.1590/S1415-47572009005000058. Epub 2009 Sep 1.

27.

A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).

Caleffi M, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B.

BMC Public Health. 2009 Mar 13;9:83. doi: 10.1186/1471-2458-9-83.

28.

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.

Palmero EI, Schüler-Faccini L, Caleffi M, Achatz MI, Olivier M, Martel-Planche G, Marcel V, Aguiar E, Giacomazzi J, Ewald IP, Giugliani R, Hainaut P, Ashton-Prolla P.

Cancer Lett. 2008 Mar 8;261(1):21-5. doi: 10.1016/j.canlet.2007.10.044. Epub 2008 Jan 11.

PMID:
18248785
29.

Cysteamine prevents and reverses the inhibition of creatine kinase activity caused by cystine in rat brain cortex.

Fleck RM, Rodrigues Junior V, Giacomazzi J, Parissoto D, Dutra-Filho CS, de Souza Wyse AT, Wajner M, Wannmacher CM.

Neurochem Int. 2005 Apr;46(5):391-7.

PMID:
15737437

Supplemental Content

Loading ...
Support Center